Background and Objectives: Kidney failure patients report a high symptom burden, which likely increase while on dialysis due to physical and mental stressors and decrease after kidney transplantation due to restoration of kidney function.
Design, Setting, Participants, and Measurements: We leveraged a 2-center prospective study of 1,298 kidney transplant candidates and 521 recipients (5/2014-3/2020). Symptom scores (0-100) at evaluation and admission for transplantation were calculated using KDQOL-SF, where lower scores represent greater burden, and burden was categorized as: very high: 0.0-71.0; high: 71.1-81.0; medium: 81.1-91.0; low: 91.1-100.0. We estimated adjusted waitlist mortality risk (competing risks regression), change in symptoms between evaluation and transplantation (n=190), and post-transplantation symptom score trajectories (mixed-effects models).
Results: At evaluation, candidates reported being moderately to extremely bothered by fatigue (32%), xeroderma (27%), muscle soreness (26%), and pruritus (25%); 16% reported high and 21% reported very high symptom burden. Candidates with very high symptom burden were at greater waitlist mortality risk (aSHR=1.67, 95%CI:1.06,2.62). By transplantation, 34% experienced an increased symptom burden while 42% remained unchanged. The estimated overall symptom score was 82.3 points at transplantation, 90.6 points at 3 months (10% improvement); the score increased 2.75 points/month (95%CI:2.38,3.13) during 0-3 months, and plateaued (-0.06 points/month, 95%CI:-0.30,0.18) from 3 months through 12 months post-transplantation. There were early (first 3 months) improvements in 9 of 11 symptoms; pruritus (23% improvement) and fatigue (21% improvement) had the greatest improvements.
Conclusions: Among candidates, very high symptom burden was associated with waitlist mortality, but for those surviving and undergoing kidney transplantation, symptoms improved.